Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
4.050
+0.090 (2.27%)
At close: Dec 20, 2024, 4:00 PM
4.060
+0.010 (0.25%)
After-hours: Dec 20, 2024, 4:26 PM EST
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 384 employees as of December 31, 2023. The number of employees increased by 122 or 46.56% compared to the previous year.
Employees
384
Change (1Y)
122
Growth (1Y)
46.56%
Revenue / Employee
$511,680
Profits / Employee
-$675,693
Market Cap
275.73M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 384 | 122 | 46.56% |
Dec 31, 2022 | 262 | 57 | 27.80% |
Dec 31, 2021 | 205 | 171 | 502.94% |
Dec 31, 2020 | 34 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
Zynex | 1,100 |
Vanda Pharmaceuticals | 203 |
COMPASS Pathways | 186 |
ProQR Therapeutics | 157 |
4D Molecular Therapeutics | 147 |
C4 Therapeutics | 145 |
Sanara MedTech | 108 |
AMLX News
- 3 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Investors to Reach Out - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Connect - Accesswire
- 17 days ago - Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia - Business Wire
- 24 days ago - Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
- 26 days ago - Amylyx: AMX0035 PSP Data In Mid-2025 Is Just One Program Moving Along - Seeking Alpha
- 4 weeks ago - Best Cheap Stocks To Buy Now (Under $10) - Kiplinger
- 6 weeks ago - Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2024 Earnings Call Transcript - Seeking Alpha